SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sewell, R. D. E.
Right arrow Articles by Sherstnev, V. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sewell, R. D. E.
Right arrow Articles by Sherstnev, V. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Does the human leukaemia differentiation factor fragment HLDF6 improve memory via brain DNA and protein synthesis?

Robert D. E. Sewell

Welsh School of Pharmacy, Cardiff University, Redwood Building, Cathays Park, King Edward VII Ave, Cardiff CF10 3XF, UK, sewell{at}cardiff.ac.uk

Marina A. Gruden

P. K. Anokhin Institute of Normal Physiology, RAMS, Mohovaya St 11, Building 4 125009, Moscow, Russia

David M. Pache

Welsh School of Pharmacy, Cardiff University, Redwood Building, Cathays Park, King Edward VII Ave, Cardiff CF10 3XF, UK

Zinaida I. Storogeva

P. K. Anokhin Institute of Normal Physiology, RAMS, Mohovaya St 11, Building 4 125009, Moscow, Russia

Irina A. Kostanyan

M. M. Shemyakin and U. A. Ovchinnikov Institute of Bioorganic Chemistry, RAS Miklikho-Maklaja St 16/10, 117871 Moscow, Russia

Andrei T. Proshin

P. K. Anokhin Institute of Normal Physiology, RAMS, Mohovaya St 11, Building 4 125009, Moscow, Russia

Vasily V. Yurasov

P. K. Anokhin Institute of Normal Physiology, RAMS, Mohovaya St 11, Building 4 125009, Moscow, Russia

Vladimir V. Sherstnev

P. K. Anokhin Institute of Normal Physiology, RAMS, Mohovaya St 11, Building 4 125009, Moscow, Russia

The novel human differentiating factor peptide fragment HLDF6 (Thr-Gly-Glu-Asn-His-Arg) was synthesized and purified. HLDF6 (0.1mg/kg i.p. but not 1mg/kg i.p.) improved not only long-term (24h) memory in adult rats in the water maze behavioural paradigm but also performance in the delayed matching-to-position (DMTP) task (0.3 and 1.0 but not 0.1mg/kg i.p). Hence, HLDF6 not only enhanced allocentric spatial learning and reference memory (water maze) but also improved temporal, spatial and working memory processes in the DMTP behavioural paradigm. Immunoreactivity blotting analysis of HLDF (the protein precursor of HLDF6) was performed and the following rank order of visual intensities from brain structures was noted: hippocampus cerebral cortex cerebellum hypothalamus striatum. Subsequently, we found that the highest absolute levels of HLDF were expressed in the hippocampus and cerebral cortex as detected by ELISA. We also demonstrated that HLDF6 enhanced [3H]-thymidine and [14C]-leucine incorporation into whole brain and hippocampal homogenates (maxima occurring within the range 10 12-10 6 M) suggesting that this hexapeptide promoted de novo DNA and protein biosynthesis. We discuss this data in terms of their implications for links with other integrative metabolic pathways involving immediate early gene activation which may underpin a potential application for HLDF6 in limiting memory impairments associated with neurodegenerative diseases.

Key Words: learning • memory • human leukaemia differentiating factor HLDF6 • DNA • protein biosynthesis

Journal of Psychopharmacology, Vol. 19, No. 6, 602-608 (2005)
DOI: 10.1177/0269881105056645


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
R. U. Ostrovskaya, M. A. Gruden, N. A. Bobkova, R. D. E. Sewell, T. A. Gudasheva, A. N. Samokhin, S. B. Seredinin, W. Noppe, V. V. Sherstnev, and L. A. Morozova-Roche
The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model
J Psychopharmacol, August 1, 2007; 21(6): 611 - 619.
[Abstract] [PDF]



Advertisement